Evidence map›Paper›PMID 40073635›Full record

ArticlePoultry science2025

Lactobacillus reuteri alleviates diquat induced hepatic impairment and mitochondrial dysfunction via activation of the Nrf2 antioxidant system and suppression of NF-κB inflammatory response.

Shenao Zhan, Lianchi Wu, Yujie Lv, Weichen Huang, Chaoyue Ge, Zhaoying Hu, Xinyu Shen, Gang Lin, Dongyou Yu, Bing Liu

Abstract read
In one paragraph

Article in Poultry science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phase-engineered MoSJournal of nanobiotechnology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Antioxidant and Anti-Inflammatory Activities of Probiotic Strains.International journal of molecular sciences · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Effect ofFrontiers in veterinary science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shenao ZhanCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Lianchi WuCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Yujie LvCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Weichen HuangCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Chaoyue GeCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Zhaoying HuCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Xinyu ShenCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Gang LinInstitute of Quality Standards and Testing Technology for Agricultural Products, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Dongyou YuCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China; ZJU-Xinchang Joint Innovation Centre (TianMu Laboratory), Xinchang 312500, China. Electronic address: dyyu@zju.edu.cn.
Bing LiuCollege of Animal Sciences, Zhejiang University, Hangzhou 310058, China; ZJU-Xinchang Joint Innovation Centre (TianMu Laboratory), Xinchang 312500, China. Electronic address: bing.liu@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence has shown that elevated oxidative stress and inflammatory response leads to hepatic impairment and dysfunction of hens during the aging process. This study was conducted to investigate the potential regulatory mechanisms of Lactobacillus reuteri (L. reuteri) in alleviating hepatic oxidative stress and dysfunction induced by diquat (DQ) exposure. A total of 480 48-wk-old Jingbai hens were randomly assigned to 4 groups: control group (Con), L. reuteri group (L.R), diquat-challenged group (DQ), and L. reuteri protective group (L.R+DQ). The results demonstrated that DQ exposure induced oxidative damages and lipid metabolism disorders manifested as the elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, triglyceride (TC) contents in serum and lipid accumulation in liver. L. reuteri supplementation alleviated DQ-induced liver oxidative injury, reflected by repairing the morphology of liver and decreasing the AST and ALT activities in serum. L. reuteri decreased the hepatic malonaldehyde (MDA) accumulation and enhanced the total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) activities in liver through regulating the nuclear factor erythroid 2-related factor 2 (Nrf2) and hemeoxygenase-1 (HO-1) mediated antioxidant system. In addition, L. reuteri curtailed reactive oxygen species (ROS) production and mitigated the depletion of membrane potential and thus recovering mitochondrial function disturbed by DQ challenge. Moreover, L. reuteri inhibited hepatic toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor-kappa B (NF-κB) pathway activation, downregulated the pro-inflammatory-response-related gene expressions (IL-1β, TNF-α, and IL-6) and the phosphorylation levels of IκBα, and p65 in liver and thus reducing hepatic inflammatory response and apoptosis. Overall, the findings indicate that L. reuteri provides significant protection against oxidative stress, mitochondrial impairment, inflammatory response and apoptosis caused by DQ in laying hens, and highlight its potential as a therapeutic probiotic for alleviating oxidative stress and mitochondrial dysfunction to prolong the health of aging poultry.

Indexed as

Chemical and Drug Induced Liver InjuryChickensDiquatLimosilactobacillus reuteriPoultry DiseasesProbioticsAnimal FeedAnimalsAntioxidantsAvian ProteinsDietFemaleInflammationLiverMitochondriaNF-E2-Related Factor 2AntioxidantsAvian ProteinsDiquatNF-E2-Related Factor 2NF-kappa BApoptosisInflammationLiver injuryMitochondrial dysfunctionOxidative stress

Identifiers

PMID40073635
PMCPMC11951011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.